Optimum usage of wavefront technologies explored in seminar

WaveLight hosted the educational symposium "Confronting the Wavefront: The Scientific Rationale for Wavefront-Optimized and Wavefront-Guided Treatments" at the Four Seasons hotel during the American Society of Cataract and Refractive Surgery annual meeting.

The purpose of the seminar was to illustrate how using the right customization method is a key element for successful refractive treatment. Panel members discussed the scientific background of wavefront-optimized and wavefront-guided technology and the clinical benefits of each approach.

Theo Seiler, MD, PhD, was chairman and moderator of the forum. Guy M. Kezirian, MD, FACS, served as co-chairman and led off the event with an overview of wavefront technology and a look at its future. The panel consisted of Dr. Seiler; Charles Moore, MD; Daniel Durrie, MD; and Jay Bansal, MD.

Titles of the program segments were: "The Rationale Behind the Development of Wavefront-optimized Ablations" by Dr. Seiler; "Interim Results from Ongoing FDA Clinical Trials for Wavefront-Guided Treatments with the Allegretto Wave" by Dr. Kezirian; "Comparison of Optical Zones with Different Ablation Profiles" by Dr. Moore; and "Preliminary Results from a Comparison Study of Hyperopia using Wavefront-Optimized Technology" by Dr. Durrie.

Dr. Moore may have summed it up best by telling the audience: "You can't afford not to have wavefront on your platform."